Greg Morcroft - Author for 24/7 Wall St.
Lastest Stories by Greg Morcroft
Weber shares jumped after the iconic grill and smoker maker confirmed its largest shareholder has offered a 24% premium to buy the part of the company it does not already own.
Published:
Immunic shares tumbled after the biotech company said a trial review of its psoriasis treatment candidate produced unexpected results.
Published:
German shoemaker and athletic retailer Adidas said a one-two punch of weakening sales and pricing in western markets and ongoing production woes in China hit results.
Published:
Tractor Supply shares slipped on Thursday as investors digested an earnings report and positive company guidance.
Published:
Dan Loeb said he believed a stand-alone pet business could be worth $20 billion.
Published:
Charles Schwab said that rising interest rates and robust customer inflows drove the company's most profitable quarter ever.
Published:
Relmada Therapeutics shares tumbled after the biotechnology company said its most promising drug failed in late-stage testing.
Published:
Bowlero is expanding operations in the Midwest.
Published:
Electric-vehicle maker Lucid says it is on track to meet its revised 2022 sales guidance after it delivered just under 1,400 cars in the third quarter.
Published:
The Peloton co-founder and the former chief executive officer who stepped down in September had faced several broker margin calls leading up to his departure.
Published:
An activist investment firm focusing on the pharmaceutical sector has put pressure on Amarin to hold a special meeting to straighten out its board issues and halt a slide.
Published:
Weber shares were volatile after Bloomberg News reported it hired Centerview Partners to handle a proposed debt sale to its largest shareholder.
Published:
Shares of Uber Technologies, Lyft, and DoorDash fell after the federal government proposed rule that would make the companies' drivers employees rather than contractors.
Published:
Norwegian Cruise Line has removed all COVID-19 testing, masking and vaccination requirements to better aligned with peers' policies.
Published:
Argus Research analysts downgraded retail and manufacturing giant Nike, citing discounted inventory eating away at gross margins.
Published: